AI Therapist Receives UK Medical License: Digital Therapy Officially Enters Healthcare System

The UK's General Medical Council has granted a full practicing license to MindBridge, an AI-powered cognitive behavioral therapy platform, making it the first non-human entity authorized to deliver mental health treatment within the National Health Service.

MindBridge, developed by London-based mental health firm CalmLogic, uses a large language model fine-tuned on more than 800,000 anonymized therapy transcripts and validated against clinical outcome data from NHS trusts. The system delivers structured CBT sessions through text and voice interfaces, with built-in escalation protocols that refer patients to human therapists when clinical risk is detected.

The licensing decision followed a two-year supervised pilot across four NHS trusts in England, during which MindBridge treated over 6,200 patients with mild to moderate anxiety and depression. Outcome data published in The Lancet Digital Health showed symptom reduction comparable to human-delivered CBT, with patient satisfaction scores averaging 4.2 out of 5.

"MindBridge doesn't replace therapists — it extends the system's capacity," said Dr. Aisha Patel, CalmLogic's chief medical officer. NHS mental health services currently face average waiting times of 18 weeks for talking therapies, a backlog the government has pledged to reduce.

Under the license conditions, MindBridge must operate within defined clinical guardrails. It cannot treat patients with severe mental illness, active suicidality, or personality disorders. Every session is reviewed by a supervising clinician within 48 hours, and the system undergoes quarterly audits by an independent clinical board.

The British Psychological Society expressed cautious support, noting that the platform's safety record during the pilot was "reassuring." However, some practitioners remain uneasy about licensing software as a medical practitioner. "There's a difference between a useful tool and a licensed clinician," said Dr. Rachel Okonkwo, a consultant psychiatrist in Manchester.

CalmLogic says NHS rollout will begin in June, initially serving patients on waiting lists for mild anxiety treatment. The company is also pursuing regulatory clearance in Canada and Australia.